Logo
Invion investor hub

Invion CEO, Thian Chew, outlines Invion's updated human clinical trial program in our latest Corporate Presentation.



0

likes

0

questions

0

company answers

Ask a question


Your question will be sent privately to Invion. The company may choose to make this question public.

Investor Q&As

Start the conversation

Ask Invion a question about this update.